DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20180627

Study of prescription pattern of drugs used in the treatment of osteoarthritis in a tertiary care teaching hospital: an observational study

Rohini Gupta, Apoorva Malhotra, Pavan Malhotra

Abstract


Background: Osteoarthritis(OA) is a major cause of chronic pain and lower extremity disability among the elderly due to its predilection for lower extremity joints such as the knee and hip. Although Paracetomol is the initial drug of choice, NSAIDS are also frequently used in the symptomatic relief of osteoarthritis. But still, there is a need for safe and effective alternative treatments which would provide both symptomatic improvement and disease modifying effects in OA. The primary objective was to study the prescribing pattern of drugs used in the treatment of osteoarthritis.

Methods: A cross-sectional, prospective, observational study was conducted on newly diagnosed as well as old treated patients with osteoarthritis from orthopaedic outpatient department in a tertiary care teaching hospital. A total of one hundred and eighty-eight patients were enrolled after screened for the inclusion and exclusion criteria. Data was recorded in a specially designed proforma which include information regarding the demographic profile of the patients and about the pattern of drugs prescribed.

Results: Out of one hundred eighty-eight patients who were affected with Osteoarthritis, females (57.9%) were more commonly affected than males (42%). OA knee (77%) either unilateral or bilateral was most commonly affected, followed by hip joint, spine and other joints. NSAIDS were more frequently prescribed in 76.6% patients than paracetamol which was prescribed in only 34 % of patients and that only in combination with NSAIDS and opioids. Various other drugs were also used as adjunct therapies that included gastroprotective agents in 49% of patients, Calcium in 54% of patients, Vitamin D3 supplements in 51% of patients and symptomatic slow acting drugs for OA (SYSADOA) which included diacerin and glucosamine sulfate as combination in 11% of patients.

Conclusions: Our study showed Osteoarthritis knee being most common among female patients. Paracetamol and SYSADOA being under prescribed and NSAIDS are the most frequently used drugs in OA. National drug policy is needed to rationalize the drug use and bring awareness among the prescribing doctors. 


Keywords


NSAIDS, Osteoarthritis, Paracetamol, SYSADOA

Full Text:

PDF

References


Goldring SR, Goldring MB. Clinical aspects, pathology and pathophysiology of osteoarthritis. J Musculoskeletal Neuronal Interaction. 2006;6(4):376.

David JH, Victoria LJ. The Epidemiology of Osteoarthritis; Best Practice and Research. Clinical Rheumatology. 2014;28:5-15.

Muirden KD. Community oriented program for the control of Rheumatic diseases: Studies of rheumatic diseases in the developing world. Curr opin Rheumatol. 2005;17:153-6.

Lohmander LS, de Verdier MG, Rollof J, Nilsson PM, Engstrom G. Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study. Annals Rheumatic Diseases. 2009;68(4):490-496.

Mohamed A, Nahid A, Zia RU, Misbahullah K. A study on prescribing patterns in the management of arthritis in the department of Orthopaedics. Scholars Research Library. 2012;4(1):5-27.

Rintelen B, Neumann K, Leeb BF. A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis. Archives Internal Med. 2006;166(17):1899-906.

Lohmander LS, Roos EM. Clinical update: treating osteoarthritis. The Lancet .2008;370(96):2082-2084.

Dyer E, Heflin MT.Osteoarthritis: its course in older patients and current treatment methods. Clinical Geriatrics. 2005;13(7):18.

Abramson SB. The role of NSAIDS in the treatment of osteoarthritis. In Osteoarthritis. Edited by: Brandt KD, Doherty M, Lohmander LS. Oxford: Oxford University Press; 2003:251-8.

Sam S, Anbu J, Kulandaiammal M, Prakash M. Pattern of drug prescribing in osteoarthritis patients attending orthopaedic outpatient department of a tertiary care hospital. J Drug Delivery Therapeutics. 2016;6(5):14-17.

Velentina BP. Pharmacy practice. 2009;7(2):88-93.

Recommendations, EULAR. An evidence-based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62(12):1145-55.

Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage. 2008;16(2):137-62.

Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, et al. EULAR Recommendations 2003: an evidence-based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Annals rheumatic diseases. 2003;62(12):1145-55.

Bernatsky S, Feldman D, Civita MD, Haggerty J, Tousignant P, Legare J, et al. Clin Rheumatol. 2010;29:645-57.

Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. The Lancet. 2001;357(9252):251-6.

Towheed TE, Anastassiades TP, Shea B, Houpt J, Welch V, Hochberg MC. Glucosamine therapy for treating osteoarthritis (Cochrane review): In: Cochrane Library. Issue 2. In: Oxford: Update Software, 2001.

Pavelka K, Trč T, Karpaš K, Sedláčková M, Vlasáková V, Böhmová J, et al. The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: A randomized, multicenter, double‐blind, placebo‐controlled study with primary end points at two months after the end of a three‐month treatment period. Arthritis Rheumatology. 2007;56(12):4055-64.

Toegel S, Wu SQ, Piana C, Unger FM, Wirth M, Goldring MB, et al. Comparison between chondroprotective effects of glucosamine, curcumin, and diacerein in IL-1β-stimulated C-28/I2 chondrocytes. Osteoarthritis cartilage. 2008;16(10):1205-12.

Yuen YH, Chang S, Chong CK, Lee SC, Critchlev JA, Chan JC. Drug utilization in a hospital general medical outpatient clinic with particular reference to antihypertensive and antidiabetic drugs. J Clin Pharm Ther. 1998;23:287-94.

Bergman U, Popa C, Tomson Y, Wettermark B, Einarson TR, Åberg H, et al. Drug utilization 90%–a simple method for assessing the quality of drug prescribing. European J clinical pharmacology. 1998;54(2):113-8.

Ullal DS, Narendranath S, Kamath KR, Pai SM, Kamath US, Savur AD. Prescribing Pattern for Osteoarthritis in a Tertiary Care Hospital. J Clinical and Diagnostic Research. 2010;(4):2421-6.

Bishnoi M, Kumar A, Kulkarni SK. Prescription monitoring of management pattern of osteoarthritis with non-steroidal anti-inflammatory drugs at PUHC, Chandigarh in India. Indian J Pharmaceutical Sci. 2006;68(4):525-7.

Jhanwar P. Drug Utilization Study of Osteoarthritis in a Tertiary Care Teaching Hospital of Rajasthan. International J Pharma Sci Review Res. 2013;14(2):35-37.

Bruyere O, Burlet N, Delmas PD, Rizzoli R, Cooper C, Reginster JY. Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system. BMC Musculoskeletal Disorders. 2008; 9(1):165.

Richard CM, Bars ML, Schimdely N, Dougados M. Paracetamol in osteoarthritis of the knee. Ann Rheum Dis. 2004;63:923-30.